Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial CTSU/NSABP-B43
A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In-Situ Resected by Lumpectomy.
Type:
Treatment
Phase:
Phase III
Status:
Closed to Accrual with Ongoing Follow-up
Treatments:
Immunotherapy, Radiation: External
Randomized:
Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Diane Ling, M.D.
Other Trial Staff:
Jessica Levano, R.N., Shamim Jhimlee, Coordinator, Laurie De Oliveira, Coordinator, Amanda Luna, D.M., Kristy Watkins, R.N.
Staff may
log in
to see study documents.
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.